Assessment of liver volume with computed tomography and comparison of findings with ultrasonography

Abdominal Imaging

Volumn 39, Issue 6, 2014, Pages 1153-1161

  Bora, Aydın ^a   Alptekin, Cem ^a   Yavuz, Alpaslan ^a   Batur, Abdussamet ^a   Akdemir, Zülküf ^a   Berköz, Mehmet ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Computed tomography; Hepatosteatosis; Liver attenuation index; Ultrasonography

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; IMAGE QUALITY; LIVER; MALE; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CONTRAST MEDIA; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; ORGAN SIZE; RADIOGRAPHIC IMAGE ENHANCEMENT; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937965258     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-014-0146-5     Document Type: Article

References (29)

1. Isomaa B, Almgren P, Tuomi T, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689
2. González AS, Guerrero DB, Soto MB, et al. (2006) Metabolic syndrome, insulin resistance and the inflammation markers Creactive protein and ferritin. Eur J Clin Nutr 60:802–809
3. Akbar DH, Kawther AH (2006) Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don’t know. Med Sci Monit 12:23–26
4. Kim D, Choi SY, Park EH, et al. (2012) Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 56:605–613
5. Oza N, Eguchi Y, Mizuta T, et al. (2009) A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol 44:1203–1208
6. Saadeh S, Younossi ZM, Remer EM, et al. (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745–750
7. Longo R, Pollesello P, Ricci C, et al. (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281–285
8. Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749
9. Tobari M, Hashimoto E, Yatsuji S, Torii N, Shiratori K (2009) Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med 48:739–746
10. Castera L (2008) Non-invasive diagnosis of steatosis and fibrosis. Diabetes Metab 34:674–679
11. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD (2008) Non-invasive means of measuring hepatic fat content. World J Gastroenterol 14:3476–3483
12. Lee JY, Kim KM, Lee SG, et al. (2007) Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 47:239–244
13. Schuchmann S, Weigel C, Albrecht L, et al. (2007) Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Eur J Radiol 62:416–422
14. Boyce CJ, Pickhardt PJ, Kim DH, et al. (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628
15. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137:727–729
16. Limanond P, Raman SS, Lassman C, et al. (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280
17. Mortelé KJ, Cantisani V, Troisi R, de Hemptinne B, Silverman SG (2003) Preoperative liver donor evaluation: imaging and pitfalls. Liver Transpl 9:S6–S14
18. Wang Z, Xu M, Peng J, et al. (2013) Prevalence and associated metabolic factors of fatty liver disease in the elderly. Exp Gerontol 48:705–709
19. 1H-magnetic resonance spectroscopy. Transpl Proc 44:955–958
20. de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B (2012) Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 32:911–918
21. Kwon HJ, Kim KW, Lee SJ, et al. (2013) Value of the ultrasound attenuation index for noninvasive quantitative estimation of hepatic steatosis. J Ultraso Med 32:229–235
22. Akcam M, Boyaci A, Pirgon O, Koroglu M, Dundar BN (2013) Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. Clin Imaging 37:504–508
23. Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21:3–16
24. Ijaz S, Yang W, Winslet MC, Seifalian AM (2003) Impairment of hepatic microcirculation in fatty liver. Microcirculation 10:447–456
25. Linguraru MG, Sandberg JK, Jones EC, Petrick N, Summers RM (2012) Assessing hepatomegaly: automated volumetric analysis of the liver. Acad Radiol 19:588–598
26. Lim SJ, Jeong YY, Ho YS (2006) Automatic liver segmentation for volume measurement in CT Images. J Vis Commun Image R 17:860–875
27. Powell EE, Cooksley WG, Hanson R, et al. (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74–80
28. Reid AE (2001) Nonalcoholic steatohepatitis. Gastroenterology 121:710–723
29. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438